Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Target prices reflect the market consensus (mean/high/low), not individual research firms. 10 actions collected · 10 in the last 12 months.
Auto-generated summary combining US and Korean research and earnings · not investment advice
Celltrion has shown a positive earnings trend, with revenue and earnings per share (EPS) consistently increasing for the past four consecutive quarters. Both revenue and EPS continued their upward trend from Q2 2025 to Q2 2026. Analysts recently issued a 'Hold' rating, but without specific price targets or detailed investment opinions, understanding the overall consensus remains limited.
—
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 08. 03. | SK증권 | — | Maintain | — → — | — | 2Q26 Re: 수익성 개선 본격화 |
| 2026. 07. 28. | 미래에셋증권 | — | Maintain | — → — | — | Top-Tier에 걸맞은 실적. 경쟁사 대비 저평가 |
| 2026. 07. 28. | iM증권 | — | Maintain | — → — | — | 이제는 믿을맨 포지션 |
| 2026. 07. 28. | DS투자증권 | — | Maintain | — → — | — | 2Q26 Re: 기대를 뛰어넘는 가파른 성장 |
| 2026. 07. 28. | 유안타증권 | — | Maintain | — → — | — | 2Q26Re: 계속되는 신제품 효과 |
| 2026. 07. 28. | 대신증권 | — | Maintain | — → — | — | 이익 레벨업, 하반기가 더 기대되는 이유 |
| 2026. 07. 06. | IBK투자증권 | — | Maintain | — → — | — | 신규 바이오시밀러가 증명한 이익 체력 |
| 2026. 07. 06. | 키움증권 | — | Maintain | — → — | — | 높아지는 실적 신뢰도 |
| 2026. 05. 27. | IBK투자증권 | — | Maintain | — → — | — | CSID 후기: 오픈 이노베이션으로 맞춘 신약 .. |
| 2026. 05. 20. | 대신증권 | — | Maintain | — → — | — | 이제 보이기 시작한다 |
